These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11746716)

  • 21. Prediction of detached personality in healthy subjects by low dopamine transporter binding.
    Laakso A; Vilkman H; Kajander J; Bergman J; paranta M; Solin O; Hietala J
    Am J Psychiatry; 2000 Feb; 157(2):290-2. PubMed ID: 10671406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
    Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
    J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cluster C personality disorder has no independent effect on striatal dopamine transporter densities in major depression.
    Laasonen-Balk T; Viinamäki H; Kuikka J; Husso-Saastamoinen M; Lehtonen J; Halonen P; Tiihonen J
    Psychopharmacology (Berl); 2001 Apr; 155(1):113-4. PubMed ID: 11374331
    [No Abstract]   [Full Text] [Related]  

  • 25. Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways.
    Silveira MM; Malcolm E; Shoaib M; Winstanley CA
    Behav Brain Res; 2015 Mar; 281():86-95. PubMed ID: 25529186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum.
    Zhou FM; Liang Y; Dani JA
    Nat Neurosci; 2001 Dec; 4(12):1224-9. PubMed ID: 11713470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role of cholinergic transmission from the laterodorsal tegmental nucleus to the ventral tegmental area in cocaine-induced place preference.
    Shinohara F; Kihara Y; Ide S; Minami M; Kaneda K
    Neuropharmacology; 2014 Apr; 79():573-9. PubMed ID: 24467849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter: basic aspects and neuroimaging.
    Piccini PP
    Mov Disord; 2003 Oct; 18 Suppl 7():S3-8. PubMed ID: 14531039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats.
    Yalcin M; Erturk M
    Neuropeptides; 2007 Apr; 41(2):103-10. PubMed ID: 17222905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
    Ray M; Bohr I; McIntosh JM; Ballard C; McKeith I; Chalon S; Guilloteau D; Perry R; Perry E; Court JA; Piggott M
    Neurosci Lett; 2004 Dec; 372(3):220-5. PubMed ID: 15542244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
    van Dyck CH; Seibyl JP; Malison RT; Laruelle M; Wallace E; Zoghbi SS; Zea-Ponce Y; Baldwin RM; Charney DS; Hoffer PB
    J Nucl Med; 1995 Jul; 36(7):1175-81. PubMed ID: 7790941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
    Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia.
    Albin RL; Cross D; Cornblath WT; Wald JA; Wernette K; Frey KA; Minoshima S
    Ann Neurol; 2003 Apr; 53(4):528-32. PubMed ID: 12666122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
    Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.
    Barak S; Weiner I
    Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice.
    Zarrindast MR; Hoseindoost S; Nasehi M
    Behav Brain Res; 2012 Mar; 228(1):116-24. PubMed ID: 22155612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.